The RECOVERED Study is a Canada-wide study being conducted by the UBC Reproductive Infectious Diseases Program and is investigating Respiratory Syncytial Virus (RSV) vaccines in pregnancy and infant RSV monoclonal antibody. The RECOVERED study aims to broaden our understanding of vaccine attitudes, pregnancy outcomes, and infant outcomes related to maternal vaccination and infant monoclonal antibody for the prevention of severe RSV infection. The data are being collected from pregnant women and people, regardless of vaccination status. By gathering online survey data on knowledge and perception of RSV and feelings, opinions, and attitudes towards RSV vaccination and infant monoclonal antibody, this study will examine the acceptability, safety, and efficacy of these RSV prevention products among pregnant people in Canada. This information will be useful to public health officials deciding on public health programs, care providers recommending products to their patients, and future parents making informed health decisions during pregnancy.
The RECOVERED project will open for recruitment in the coming weeks, please check back soon!
Coordinating Centre Lead: Dr. Deborah Money, MD, FRCSC, Professor; University of British Columbia Depts. of Obstetrics & Gynecology, Medicine, SPPH, Clinician Scientist, Women’s Health Research Institute
For further information, email the RECOVERED Team at recovered.rsv@ubc.ca
For supporting information please reference the sections below
Protocols – RECOVERED
